Sign in
4

Changes in Ownership

Pacira BioSciences, Inc. Filed Acc 0001628280-26-074533

Chief Commercial Officer returned 100,934.27 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Teehan Brendan Chief Commercial Officer 2026-11-17 Returned to the company −100,934.27 $36.50 $3,684,101 0 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Teehan Brendan Chief Commercial Officer 2026-11-17 Returned to the company · Stock Option (Right to Buy) −99,500 $26.59 2036-02-04 99,500 0 D: show line 2 in the form
Loading xslF345X06/wk-form4_1794951403.xml…